Bluejay Diagnostics (BJDX) Interest & Investment Income (2024 - 2026)
Bluejay Diagnostics recorded quarterly Interest & Investment Income of $18859.0 in Q1 2026, down 40.21% quarter-over-quarter from $31543.0 in Q4 2025, and up 5.94% year-over-year from $17801.0 in Q1 2025.
Bluejay Diagnostics' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $18859.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 5.94% year-over-year to $18859.0; the TTM figure through Mar 2026 stood at $98617.0 (down 26.15% YoY), while the FY2025 annual figure was $97559.0, down 33.1% from the prior year.
- Interest & Investment Income came in at $18859.0 for Q1 2026 at Bluejay Diagnostics, down from $31543.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $61692.0 in Q3 2024 to a low of $15408.0 in Q2 2024.
- A 3-year average of $29137.9 and a median of $29254.0 in 2025 frame the typical range for Interest & Investment Income.
- On a YoY basis, Interest & Investment Income climbed as much as 89.86% in 2025 and fell as far as 69.27% in 2025.
- Bluejay Diagnostics' Interest & Investment Income stood at $38632.0 in 2024, then decreased by 18.35% to $31543.0 in 2025, then sank by 40.21% to $18859.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $18859.0, $31543.0, and $18961.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | 18,859.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,859.00 |
| Dec 31, 2025 | 31,543.00 |
| Sep 30, 2025 | 18,961.00 |
| Jun 30, 2025 | 29,254.00 |
| Mar 31, 2025 | 17,801.00 |
| Dec 31, 2024 | 38,632.00 |
| Sep 30, 2024 | 61,692.00 |
| Jun 30, 2024 | 15,408.00 |
| Mar 31, 2024 | 30,091.00 |